Patheon posts loss as costs rise

(Reuters) – Contract drugmaker Patheon Inc reported its fourth consecutive quarterly loss hurt by higher costs. First-quarter net loss was $19.4 million, or 15 cents per share, compared with a profit of $3.5 million, or 2.7 cents per share, a year ago. Patheon said the consultation fees paid for the strategic review of its commercial business arm in the UK rose this quarter. As a result selling, general and administrative expenses rose 24 percent to $34.5 million. …